Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity
Laskey, Robin, Richard, Scott, Smith, Ashlee, Lin, Jeff, Beck, Tiffany, Lesnock, Jamie, Kelley, Joseph, Olawaiye, Alexander, Sukumvanich, Paniti, Krivak, ThomasLanguage:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S57425
Date:
March, 2014
File:
PDF, 432 KB
english, 2014